P12-18 Countdown to 2027 – maximising the use of NAMs for food safety assessment: closing the gap for regulatory assessments in Europe
An increasing number of New Approach/Non-Animal Methodologies (NAMs) has been developed over the years, with the aim to provide more informative, more efficient and more ethical risk assessments. This evolution in safety assessment strategies is also observed in the food sector, with a growing effor...
Uloženo v:
| Vydáno v: | Toxicology letters Ročník 411; s. S142 - S143 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Elsevier B.V
01.09.2025
|
| ISSN: | 0378-4274 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | An increasing number of New Approach/Non-Animal Methodologies (NAMs) has been developed over the years, with the aim to provide more informative, more efficient and more ethical risk assessments. This evolution in safety assessment strategies is also observed in the food sector, with a growing effort to move away from animal testing. The ambition of the European Food Safety Authority (EFSA) is to integrate the use of NAMs into risk assessments of regulated food products by 2027, leading to “the minimisation of animal testing”. Despite this objective, the use of NAMs remains limited in EU food evaluations and animal studies are still being requested for regulated food products. To address this, we review several NAMs relevant for food safety assessment and reflect on their presence in EU food safety regulation and sectoral guidance. We also suggest amendments to the EU food regulatory environment and propose potential research activities that could support the broader implementation of such NAMs.
Fourteen NAMs of relevance to food safety are categorised based on: 1. the potential to inform hazard, exposure or risk, 2. their assessment domain, i.e. biological and chemical, and 3. the history of use of such methods, e.g. long standing and innovative method. These NAMs are: in silico methods, exposure-based waiving, read-across, genotoxicity testing, safe strain lineage, history of safe use, omics technologies, cellular stress pathways, pharmacological profiling, phenotypic profiling, adverse outcome pathways, approaches to assess allergenicity and toxigenicity, tools and approaches for ADME characterisation and integrated approaches to testing and assessment (IATA) combining several NAMs to support risk assessment. The presence of such NAMs in EU foods regulations and sector-specific guidelines is reviewed for a diverse range of regulated products.
Sectoral guidance has recently been updated in the EU for many areas of regulated products. Most of them stress the general 3Rs principles and some guidance documents mention the potential use of specific NAMs, such as in silico approaches or exposure-based waiving, which is a significant progress. On the other hand, some NAMs are still entirely absent from the EU foods guidance and regulation, and certain sector-specific guidelines, such as those for food additives, still require the inclusion of animal studies. In addition, the explicit request for a qualification and validation of alternative approaches is believed to be a major limiting factor for their potential use to support a safety assessment. Several revisions of existing guidance are suggested in order to maximize the implementation of NAMs in food safety evaluation, including the proposal that animal testing should only be conducted “as a last resort”. For those NAMs not reflected in EU foods guidance, several research activities are required to build confidence and thereby enhance their use. |
|---|---|
| AbstractList | An increasing number of New Approach/Non-Animal Methodologies (NAMs) has been developed over the years, with the aim to provide more informative, more efficient and more ethical risk assessments. This evolution in safety assessment strategies is also observed in the food sector, with a growing effort to move away from animal testing. The ambition of the European Food Safety Authority (EFSA) is to integrate the use of NAMs into risk assessments of regulated food products by 2027, leading to “the minimisation of animal testing”. Despite this objective, the use of NAMs remains limited in EU food evaluations and animal studies are still being requested for regulated food products. To address this, we review several NAMs relevant for food safety assessment and reflect on their presence in EU food safety regulation and sectoral guidance. We also suggest amendments to the EU food regulatory environment and propose potential research activities that could support the broader implementation of such NAMs.
Fourteen NAMs of relevance to food safety are categorised based on: 1. the potential to inform hazard, exposure or risk, 2. their assessment domain, i.e. biological and chemical, and 3. the history of use of such methods, e.g. long standing and innovative method. These NAMs are: in silico methods, exposure-based waiving, read-across, genotoxicity testing, safe strain lineage, history of safe use, omics technologies, cellular stress pathways, pharmacological profiling, phenotypic profiling, adverse outcome pathways, approaches to assess allergenicity and toxigenicity, tools and approaches for ADME characterisation and integrated approaches to testing and assessment (IATA) combining several NAMs to support risk assessment. The presence of such NAMs in EU foods regulations and sector-specific guidelines is reviewed for a diverse range of regulated products.
Sectoral guidance has recently been updated in the EU for many areas of regulated products. Most of them stress the general 3Rs principles and some guidance documents mention the potential use of specific NAMs, such as in silico approaches or exposure-based waiving, which is a significant progress. On the other hand, some NAMs are still entirely absent from the EU foods guidance and regulation, and certain sector-specific guidelines, such as those for food additives, still require the inclusion of animal studies. In addition, the explicit request for a qualification and validation of alternative approaches is believed to be a major limiting factor for their potential use to support a safety assessment. Several revisions of existing guidance are suggested in order to maximize the implementation of NAMs in food safety evaluation, including the proposal that animal testing should only be conducted “as a last resort”. For those NAMs not reflected in EU foods guidance, several research activities are required to build confidence and thereby enhance their use. |
| Author | Montoya, G. Marin-Kuan, M. Wang, S. Hepburn, P. Galano, M. Reale, E. Basili, D. Punt, A. Fernandez, R. Wood, A. Piechota, S. Coulet, M. Atienzar, F. |
| Author_xml | – sequence: 1 givenname: A. surname: Wood fullname: Wood, A. organization: Unilever, Bedfordshire, UK – sequence: 2 givenname: F. surname: Atienzar fullname: Atienzar, F. organization: Coca-Cola Services, Anderlecht, Belgium – sequence: 3 givenname: D. surname: Basili fullname: Basili, D. organization: Nestlé Research, Lausanne, Switzerland – sequence: 4 givenname: M. surname: Coulet fullname: Coulet, M. organization: Nestlé Research, Lausanne, Switzerland – sequence: 5 givenname: R. surname: Fernandez fullname: Fernandez, R. organization: Food Drink Europe, Brussels, Belgium – sequence: 6 givenname: M. surname: Galano fullname: Galano, M. organization: Dsm-firmenich, Delft, Netherlands – sequence: 7 givenname: M. surname: Marin-Kuan fullname: Marin-Kuan, M. organization: Nestlé Research, Lausanne, Switzerland – sequence: 8 givenname: G. surname: Montoya fullname: Montoya, G. organization: Nestlé Research, Lausanne, Switzerland – sequence: 9 givenname: S. surname: Piechota fullname: Piechota, S. organization: Nestlé Research, Lausanne, Switzerland – sequence: 10 givenname: A. surname: Punt fullname: Punt, A. organization: Unilever, Bedfordshire, UK – sequence: 11 givenname: E. surname: Reale fullname: Reale, E. organization: Nestlé Research, Lausanne, Switzerland – sequence: 12 givenname: S. surname: Wang fullname: Wang, S. organization: PepsiCo, Leicester, UK – sequence: 13 givenname: P. surname: Hepburn fullname: Hepburn, P. organization: Unilever, Bedfordshire, UK |
| BookMark | eNp9kLtOAzEQRV0EiQT4Awr_wC629-ENBVIUhYcUHgXUlu2dDY527ch2IOko6flDvoQNQYiKYjRT3HM1OiM0sM4CQqeUpJTQ8myZRrdpIaaMsCIlPM0KNkBDkvEqyRnPD9EohCUhpMzLYojeHyhLaIWnbm1j7V4tjg73KMefbx-4kxvTmWDsAsdnwOsA2DX4bnIbcON8P67GQTYQt1iGACF0YOM51q37ZRZy9Z31sFi3Mjr_NxqwsXi29m4Fx-igkW2Ak599hJ4uZ4_T62R-f3UzncwTTQlhCWRKVVKVhEHdaBirnLJaSc6ozHmWNao_ZKUo5VyWhNdEZ8WYVZxIlnNVyOwI5fte7V0IHhqx8qaTfisoETuDYin2BsXOoCBc9AZ77GKPQf_biwEvgjZgNdTGg46idub_gi9CfYGs |
| ContentType | Journal Article |
| Copyright | 2025 Elsevier B.V. |
| Copyright_xml | – notice: 2025 Elsevier B.V. |
| DBID | AAYXX CITATION |
| DOI | 10.1016/j.toxlet.2025.07.352 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
| EndPage | S143 |
| ExternalDocumentID | 10_1016_j_toxlet_2025_07_352 S0378427425019356 |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 123 1B1 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABEFU ABFNM ABFRF ABFYP ABJNI ABLST ABMAC ABWVN ABXDB ABZDS ACDAQ ACGFO ACGFS ACIUM ACLOT ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEFWE AEIPS AEKER AENEX AEUPX AFFNX AFJKZ AFPUW AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHEUO AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AKBMS AKIFW AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLECG BLXMC CS3 DU5 EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HMT HVGLF HZ~ IHE J1W KCYFY KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSJ SSP SSZ T5K WH7 WUQ XPP ZGI ZXP ~G- ~HD ~KM 9DU AAYXX CITATION |
| ID | FETCH-LOGICAL-c1002-e3bb8ab602edfce9b412dba721a4733fb21aa8b1177a607d0c3592870a247b5a3 |
| ISSN | 0378-4274 |
| IngestDate | Sat Nov 29 07:26:23 EST 2025 Sat Oct 25 17:56:00 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1002-e3bb8ab602edfce9b412dba721a4733fb21aa8b1177a607d0c3592870a247b5a3 |
| ParticipantIDs | crossref_primary_10_1016_j_toxlet_2025_07_352 elsevier_sciencedirect_doi_10_1016_j_toxlet_2025_07_352 |
| PublicationCentury | 2000 |
| PublicationDate | September 2025 2025-09-00 |
| PublicationDateYYYYMMDD | 2025-09-01 |
| PublicationDate_xml | – month: 09 year: 2025 text: September 2025 |
| PublicationDecade | 2020 |
| PublicationTitle | Toxicology letters |
| PublicationYear | 2025 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| SSID | ssj0006465 |
| Score | 2.468227 |
| Snippet | An increasing number of New Approach/Non-Animal Methodologies (NAMs) has been developed over the years, with the aim to provide more informative, more... |
| SourceID | crossref elsevier |
| SourceType | Index Database Publisher |
| StartPage | S142 |
| Title | P12-18 Countdown to 2027 – maximising the use of NAMs for food safety assessment: closing the gap for regulatory assessments in Europe |
| URI | https://dx.doi.org/10.1016/j.toxlet.2025.07.352 |
| Volume | 411 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: ScienceDirect Freedom Collection - Elsevier issn: 0378-4274 databaseCode: AIEXJ dateStart: 19950101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.sciencedirect.com omitProxy: false ssIdentifier: ssj0006465 providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6FlgMSQlBAtAU0B9RL6shev7kFaAWIRpEIkJu16wdyFewocSuXE0fu_Az-Fb-EWY-9jqCq6IFDLHu1jzjzZWZ2XsvYM5mZsWWa0jBjl-MGxfcMYYrY8JAvJLFrCq856_DjO38yCebzcDoY_OxyYc4XflEEdR0u_yupsQ2JrVJnr0FuPSk24D0SHa9Idrz-E-GnFjesoEk2rxLcYyvtUtkehl1cgz38Iuoc6dtlSp2RPX8yPmmKM-CnTIZrkaloTqErdyrbQbwo9ajPYtn0XtFp9spX33duomzJ0r-p_s7KOo-p6tOiySPSGv2nNvRnPNIQVAVfv1L897FufSHWOWV0v9Jt-KoL8qmcjDatGNzVYVo6ewt3sw6nE3s6zuy0fJh463uL6nC1chof7UtlAJkjTkdVWePiI7Waqs9qu7yXeZ2f_w9RqAMUu9i304hmidQskelHOMsNts19N0QWuj1-czR_qwW_5zQnl-pX6TI1m3DCv7_N5ZrQhnYzu8vutNsSGBOc7rFBWuywgynVNb84hFmfprc-hAOY9hXPL3bYbTL-AuW03WffCYOgMQhVCQqD8OvbD-jRB4gjQPRBmYFCHyCeQKEPCH3QA-o5tNhrxiD2mr499ja6riEvgLD3gH04Ppq9fG20R34YimNwI7WlDIT0TJ4mWZyG0rF4IoXPLeH4tp1JvBGBVJEGwjP9xIxtN1S-esEdX7rCfsi2irJIHzFAwSOtjHtSedpt7BEmuH0RqLVJabmx3GVG9_NHS6rsEl1F9l3mdzSKWu2UtM4IgXflyL1rrrTPbvV_kcdsq1qdpU_Yzfi8yterpy3qfgO46bJv |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P12-18+Countdown+to+2027+%E2%80%93+maximising+the+use+of+NAMs+for+food+safety+assessment%3A+closing+the+gap+for+regulatory+assessments+in+Europe&rft.jtitle=Toxicology+letters&rft.au=Wood%2C+A.&rft.au=Atienzar%2C+F.&rft.au=Basili%2C+D.&rft.au=Coulet%2C+M.&rft.date=2025-09-01&rft.issn=0378-4274&rft.volume=411&rft.spage=S142&rft.epage=S143&rft_id=info:doi/10.1016%2Fj.toxlet.2025.07.352&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_toxlet_2025_07_352 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-4274&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-4274&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-4274&client=summon |